Clinical Trials

Sponsor: BioNTech Pharmaceuticals

Sponsor Study ID: BNT-122-01

Study Title: A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

CTO #: 103669

NCT Number: NCT04486378

Phase: II

Protocol Type: Treatment

Age Group: Adults

Disease Sites: Colon

Study Objectives: To demonstrate superiority of RO7198457 compared to watchful waiting in terms of DFS in chemotherapy pre-treated patients.

Study Documents    
(MUSC NetID required for document access)